A group of investors led a €15m funding round in Sensius.

A group of investors, including European Innovation Council Fund, GrayBella Capital and UCEA Capital Partners led a €15m funding round in Sensius, a Dutch medical technology company specializing in hyperthermia systems for cancer treatment. The new funding will accelerate the initiation of international clinical trials aimed at validating the efficacy and safety of Sensius’ proprietary thermotherapy platform.